These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6654469)

  • 1. Arginine vasopressin modulates the central action of angiotensin II in the dog.
    Michelini LC; Barnes KL; Ferrario CM
    Hypertension; 1983; 5(6 Pt 3):V94-100. PubMed ID: 6654469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Area postrema lesions augment the pressor activity of centrally administered vasopressin.
    Michelini LC; Barnes KL; Ferrario CM
    Clin Exp Hypertens A; 1986; 8(7):1107-25. PubMed ID: 3769219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that centrally released arginine vasopressin is involved in central pressor action of angiotensin II.
    Loń S; Szczepańska-Sadowska E; Szczypaczewska M
    Am J Physiol; 1996 Jan; 270(1 Pt 2):H167-73. PubMed ID: 8769748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central and peripheral vasopressin interact differently with sympathetic nervous system and renin-angiotensin system in renal hypertensive rabbits.
    Kumagai H; Suzuki H; Ichikawa M; Matsumura Y; Jimbo M; Ryuzaki M; Saruta T
    Circ Res; 1993 Jun; 72(6):1255-65. PubMed ID: 8495554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABA agonists inhibit the vasopressin-dependent pressor effects of central angiotensin II.
    Brennan TJ; Morris M; Haywood JR
    Neuroendocrinology; 1984 Nov; 39(5):429-36. PubMed ID: 6514131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular effects of arginine vasopressin during fluid deprivation in the rat.
    Aisenbrey GA; Handelman WA; Arnold P; Manning M; Schrier RW
    J Clin Invest; 1981 Apr; 67(4):961-8. PubMed ID: 7204578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of antagonists of the vasoconstrictor action of vasopressin in conscious dogs.
    Liard JF; Spadone JC
    J Cardiovasc Pharmacol; 1984; 6(4):713-9. PubMed ID: 6206331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of vasopressin and angiotensin to the maintenance of blood pressure after autonomic blockade.
    Hiwatari M; Nolan PL; Johnston CI
    Hypertension; 1985; 7(4):547-53. PubMed ID: 2989171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of vasopressin in the pressor response to bilateral carotid occlusion.
    DiCarlo SE; Stahl LK; Hasser EM; Bishop VS
    J Auton Nerv Syst; 1989 Jun; 27(1):1-10. PubMed ID: 2794340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vagal cold block in area postrema-lesioned dogs: interaction of vasopressin and sympathetic nervous system.
    Applegate RJ; Hasser EM; Bishop VS
    Am J Physiol; 1987 Jan; 252(1 Pt 2):H135-41. PubMed ID: 2880512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of vasopressin-induced coronary artery constriction by the vasopressin antagonist d(CH2)5Tyr(Me)-AVP.
    Kopia GA; Valocik RE
    J Cardiovasc Pharmacol; 1985; 7(5):958-63. PubMed ID: 2413308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin and angiotensin II in blood pressure control during isoflurane anesthesia in rats.
    Ullman J
    Acta Anaesthesiol Scand; 1999 Sep; 43(8):860-5. PubMed ID: 10492417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin pressor antagonist injected centrally reverses behavioral effects of peripheral injection of vasopressin, but only at doses that reverse increase in blood pressure.
    Lebrun C; Le Moal M; Koob GF; Bloom FE
    Regul Pept; 1985 Jun; 11(2):173-81. PubMed ID: 4035008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged inhibition of pressor response to vasopressin by a potent specific antagonist, [1-(beta-mercapto-beta, beta-cyclopentamethylenepropionic acid) 2-(O-methyl)tyrosine]arginine-vasopressin.
    Pang CC; Leighton KM
    Can J Physiol Pharmacol; 1981 Sep; 59(9):1008-12. PubMed ID: 6895346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and dipsogenic effects of angiotensin II administered i.c.v. in Long-Evans and Brattleboro rats.
    Harland D; Gardiner SM; Bennett T
    Brain Res; 1988 Jul; 455(1):58-64. PubMed ID: 3416193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central blood pressure effects of substance P and angiotensin II: role of the sympathetic nervous system and vasopressin.
    Unger T; Rascher W; Schuster C; Pavlovitch R; Schömig A; Dietz R; Ganten D
    Eur J Pharmacol; 1981 Apr; 71(1):33-42. PubMed ID: 6165592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of vasopressin and the sympathetic nervous system in the cardiovascular response to vagal cold block in the conscious dog.
    Hasser EM; Haywood JR; Johnson AK; Bishop VS
    Circ Res; 1984 Oct; 55(4):454-62. PubMed ID: 6148158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of renal sympathetic outflow by intracisternal hypertonic NaCl in dogs.
    Abe I; Averill DB; Ferrario CM
    Am J Physiol; 1989 Feb; 256(2 Pt 2):H411-6. PubMed ID: 2644846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin and ANG II in the control of ACTH secretion and arterial and atrial pressures.
    Brooks VL
    Am J Physiol; 1989 Feb; 256(2 Pt 2):R339-47. PubMed ID: 2537037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.